Insulet Corporation ( PODD) - Key Metrics
PODD Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $11.14 | $1.44 | $2.61 | $0.69 |
| 2025Q3 | $10 | $1.24 | $1.78 | $1.48 |
| 2025Q2 | $9.23 | $0.32 | $2.79 | $2.46 |
| 2025Q1 | $8.10 | $0.50 | $0.91 | $0.73 |
PODD Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 49.21 |
| 2025Q3 | ? | 62.24 |
| 2025Q2 | ? | 245.51 |
| 2025Q1 | ? | 130.33 |
PODD Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 0.59% | ? |
| 2025Q4 | 0.24% | ? |
| 2025Q3 | 0.48% | ? |
| 2025Q2 | 0.78% | ? |
| 2025Q1 | 0.28% | ? |
PODD
Price: $153.22
52 week price:
Earnings Per Share: 4.29 USD
P/E Ratio: 35.94
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 334800
Ebitda: 6.4 millionMarket Capitalization: 10.7 billion